Psychosocial Assessment
The repeatedly dashed hopes of patients with neuropathic pain,
to say nothing of the total emotional burden of the pain problem, can affect all
phases of patients' lives. They experience frustration, despair, anger, anxiety,
and depression.
*
Their coping skills diminish as
do
their physical capabilities, and the ravages of time, powerful medications, and dampened
spirits affect their ability to "think clearly," remember information, and concentrate.
Most patients with neuropathic pain do not have psychiatric disease, although those
that are suspected of such should be evaluated by psychiatrists. The majority of
patients with neuropathic pain will have problems with anxiety/depression, coping
skills, anger management, activity pacing, and pain-related insomnia. These aspects
of a pain problem can be assessed by a psychologist.
The psychosocial impact of the pain may ultimately be the arena
in which the most unique therapeutic intervention is possible. Assessing the patient
with neuropsychological testing or other tests for the patient being considered as
a candidate for major nerve blocks, opioid therapy, and high-technology interventional
therapies such as spinal cord stimulators or implanted intrathecal pump fosters the
selection of patients most likely to benefit from the chosen management. It is important
to gain an understanding of the patient's behaviors related to pain and the reinforcing
elements, such as (1) using the pain as a convenient excuse to avoid undesired activity,
(2) using language that implies tissue damage but which is really covering anxiety
and depression, (3) manifesting the lack of genuine motivation to improve (the motivation
of possible financial gain from a prevailing lawsuit), (4) noting the influence of
external agencies such as workman's compensation or the disability system (the loss
of independence, the dictated appointments), and (5) acknowledging the acquired "comfort"
of the pain-based lifestyle (the pain serving as an excuse from work, for free time,
and being at home).
Pain due to primarily psychological factors is profoundly different
from that associated with obvious physical causes. Overall, the thrust, once the
primary evaluation is completed, is to distill all available data into a differential
diagnosis and a working diagnosis. From this position of knowledge, the patient
and referring physician can be informed about treatment that is relevant to and rational
for the diagnosis. Thereafter, management planning begins and eventually the primary
and secondary treatment strategies can be elaborated.
Follow-up visits are an expected part of the practice of pain
medicine. Some of the same evaluation tools used initially have validity when completed
by the patient at serial visits. It is likely that the agenda of the follow-up visit
will be focused on how the patient has responded to each therapeutic modality. It
is also crucial that the patient has time to "talk with the doctor," although non-physician
health care professionals have a meritorious role in facilitating the flow of patients
in a practice and in educating patients. It is time-efficient to use a protocol
in this clinical setting, so that important aspects are not overlooked. It is fundamental
that the practice determines what outcomes are desired and/or expected, and acknowledges
that most pain conditions have a natural history, the reality of which complicates
outcomes research. Even when a patient is participating in a series of treatments
(e.g., epidural steroid injections or sympathetic nerve blocks), it is absolutely
essential to decide at each visit that the planned
treatment is still appropriate for that patient at
that time. Because the patient's individual circumstances
can change from visit to visit, the setting in which the clinical care is being provided
is different.
In general, the goal of treatment in inflammatory pain is to restore
the patient to his or her pre-pain lifestyle. In cancer pain patients, the primary
goal is to improve the patient's quality of life. In chronic, non-cancer pain, the
goals are to decrease the pain to the extent possible and improve the patient's ability
to function. As with the primary evaluation, documentation of what is said by and
to the patient and the details of treatment is necessary. Also, in patients with
neuropathic pain, just because the pain is markedly reduced or eliminated with treatment
does not mean that all of the psychosocial consequences of the pain also disappear.
Thus, a review of the patient's plan for when he or she is feeling better is needed
at early follow-up visits so that guidance can be provided to address this specific
point. Furthermore, because one wants to maintain only those treatments deemed to
be having a positive effect, the accuracy of the patient's feedback is crucial.
Given the extent of neural reorganization and our not knowing how long it takes after
injury for the nervous system to revert to normal (if that ever happens), the contemporary
theme of pain management is to continue treatment past the expected healing period
to the point that the modest goals of treatment are achieved.
 |